| # | Drug | Count |
|---|---|---|
| 0 | APIXABAN | 17 |
| 1 | IBRUTINIB | 15 |
| 2 | RISANKIZUMAB-RZAA | 13 |
| 3 | RIVAROXABAN | 13 |
| 4 | ADALIMUMAB | 10 |
| 5 | UPADACITINIB | 10 |
| 6 | VENETOCLAX | 9 |
| 7 | CLOPIDOGREL | 6 |
| 8 | LEVOTHYROXINE SODIUM | 6 |
| 9 | ASPIRIN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SEVELAMER HYDROCHLORIDE | 1 | 0.0017 |
| 1 | VERICIGUAT | 1 | 0.0010 |
| 2 | TESAMORELIN | 1 | 0.0006 |
| 3 | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | 1 | 0.0006 |
| 4 | EFGARTIGIMOD ALFA | 2 | 0.0005 |
| 5 | ZANUBRUTINIB | 2 | 0.0004 |
| 6 | IBANDRONATE SODIUM | 1 | 0.0003 |
| 7 | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | 1 | 0.0003 |
| 8 | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | 1 | 0.0003 |
| 9 | PEGLOTICASE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 30 |
| 1 | Kinase Inhibitor [EPC] | 18 |
| 2 | Interleukin-23 Antagonist [EPC] | 13 |
| 3 | Janus Kinase Inhibitor [EPC] | 10 |
| 4 | BCL-2 Inhibitor [EPC] | 9 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 7 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 5 |
| 8 | Provitamin D2 Compound [EPC] | 5 |
| 9 | Corticosteroid [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Neonatal Fc Receptor Blocker [EPC] | 2 | 0.0005 |
| 1 | Uric Acid-specific Enzyme [EPC] | 1 | 0.0003 |
| 2 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 3 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | BCL-2 Inhibitor [EPC] | 9 | 0.0001 |
| 5 | Interleukin-23 Antagonist [EPC] | 13 | 0.0001 |
| 6 | Factor Xa Inhibitor [EPC] | 30 | 0.0001 |
| 7 | Soluble Guanylate Cyclase Stimulator [EPC] | 3 | 0.0001 |
| 8 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 9 | Janus Kinase Inhibitor [EPC] | 10 | 0.0001 |